These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6362105

  • 1. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A, Rambotti P, Cernetti C, Spinozzi F, Bertotto A, Martelli MF.
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [Abstract] [Full Text] [Related]

  • 2. The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease.
    Martelli MF, Velardi A, Rambotti P, Cernetti C, Bertotto A, Spinozzi F, Bracaglia AM, Falini B, Davis S.
    Cancer; 1982 Aug 01; 50(3):490-7. PubMed ID: 7046903
    [Abstract] [Full Text] [Related]

  • 3. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients.
    Velardi A, Spinozzi F, Rambotti P, Tabilio A, Losito A, Zampi I, Cernetti C, Martelli MF, Grignani F, Davis S.
    J Clin Oncol; 1983 Feb 01; 1(2):117-25. PubMed ID: 6668495
    [Abstract] [Full Text] [Related]

  • 4. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO, Letskiĭ VB, Gavrilenkova LP.
    Eksp Onkol; 1984 Feb 01; 6(4):17-22. PubMed ID: 6389087
    [Abstract] [Full Text] [Related]

  • 5. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J, Leblay R, Guerin D, Le Prise PY, Richier JL.
    Sem Hop; 1977 Jan 23; 53(4):219-25. PubMed ID: 189435
    [Abstract] [Full Text] [Related]

  • 6. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM, Fekete B.
    Haematologia (Budap); 1982 Jan 23; 15(1):111-25. PubMed ID: 6749608
    [Abstract] [Full Text] [Related]

  • 7. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y, Rotter V, Ramot B.
    Biomedicine; 1975 Jun 30; 23(6):198-200. PubMed ID: 1082352
    [Abstract] [Full Text] [Related]

  • 8. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH, Rocklin RR, Moloney WC, David JR.
    Natl Cancer Inst Monogr; 1973 May 30; 36():99-106. PubMed ID: 4583000
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro reversal of cellular unresponsiveness induced by levamisole.
    Golding H, Golding B, Jacobson R, Lomnitzer R, Koornhof HJ, Rabson AR.
    Clin Exp Immunol; 1976 Nov 30; 26(2):295-301. PubMed ID: 791550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease.
    Catanzaro A, Spitler LE, Campbell GD, Moser KM.
    Arch Intern Med; 1981 Mar 30; 141(4):533-7. PubMed ID: 7212899
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Applicability of the leukocyte migration inhibition test in the clinical practice.
    Stanciu L, Dumitrescu D, Radu D.
    Med Interne; 1990 Mar 30; 28(4):295-303. PubMed ID: 2100874
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The in vitro effect of a calf thymus extract (thymostimulin) on the immunologic parameters of patients with untreated Hodgkin's disease.
    Martelli MF, Velardi A, Rambotti P, Cernetti C, Bracaglia AM, Ballatori E, Davis S.
    Cancer; 1982 Jan 15; 49(2):245-50. PubMed ID: 7053826
    [Abstract] [Full Text] [Related]

  • 20. Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.
    Liberati AM, Brugia M, Edwards BS, Bertoni P, Ballatori E, Puxeddu A, Grignani F.
    Cancer Immunol Immunother; 1985 Jan 15; 19(2):136-41. PubMed ID: 3872709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.